loading

Fortress Biotech Inc Azioni (FBIO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
16.71%
18.72
16.04 16.08 17.63 16.41
Cost Of Revenue
1.21%
6.143
6.218 5.44 5.755 4.939
Selling, General, and Administrative
30.92%
20.81
15.89 14.73 - -
Costs And Expenses
20.81%
28.72
23.78 20.87 24.44 52.89
Operating Income/Loss
29.29%
-10.01
-7.739 -4.789 -6.811 -36.47
Nonoperating Income/Loss
92.72%
10.93
150.03 -1.424 15.66 24.82
Income/Loss From Continuing Operations Before Tax
99.35%
0.922
142.29 -6.213 8.853 -11.65
Income Tax Expense/Benefit
93.76%
0.32
5.132 -0.816 0.026 -
Net Income/Loss
99.56%
0.602
137.16 -5.397 8.827 -11.65
Preferred Stock Dividends And Other Adjustments
0.00%
2.008
2.008 2.261 2.174 2.131
Attributable To Noncontrolling Interest
96.01%
1.07
26.79 -1.46 2.977 -27.14
Basic Average Shares
0.79%
31.79
31.54 - 27.24 26.88
Diluted Average Shares
17.24%
31.79
38.41 - 33.10 29.82
Basic Earnings Per Share
102.33%
-0.08
3.44 - 0.13 0.50
Diluted Earnings Per Share
102.84%
-0.08
2.82 - 0.11 0.45
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
Capitalizzazione:     |  Volume (24 ore):